Calculated Based on Number of Shares of Combined Company Pre-Merger (Detail)	12 Months Ended
	Dec. 31, 2018 USD ($) $ / shares shares
Number of shares of the combined company that would be owned by pre-Merger ApolloMed stockholders | shares	6,109,205	[1]
Multiplied by the price per share of ApolloMed's common stock | $ / shares	$ 10.00	[2]
Equity consideration | $	$ 61,092,050	[3]

[1] Represents the number of shares of the combined company that pre-Merger ApolloMed stockholders would own at closing of the Merger.

[2] Represents the closing price of ApolloMed’s common stock on December 8, 2017.

[3] Equity consideration Immediately following the Effective Time, pre-Merger ApolloMed stockholders continued to hold an aggregate of 6,109,205 shares of ApolloMed common stock.